Ocular penetration of cyclosporin A. III: The human eye.

The distribution of cyclosporin A (CsA) in the blood, saliva, tears, aqueous humour, vitreous, and cerebrospinal fluid has been studied after oral treatment with 5 mg/kg/day of CsA or application of 2% CsA eye drops in olive oil solution. After oral treatment all patients had high CsA levels in blood. Measurable levels of CsA were also found in the saliva and tears. Patients without any intraocular inflammation or patients with mild uveitis did not have any detectable CsA in the aqueous humour. However, patients with severe uveitis had significant levels of CsA in the aqueous humour and in the vitreous. No CsA was found in the cerebrospinal fluid of two patients with central nervous system manifestations of Behçet's disease. After local treatment with 2% CsA eye drops no detectable levels of CsA were found in the blood, the saliva, the aqueous humour, or the vitreous even in patients with severe uveitis.

[1]  K. Tabbara,et al.  Ocular bioavailability of cyclosporine after oral administration. , 1988, Transplantation proceedings.

[2]  O. Ringdén,et al.  Tissue distribution of [3H]cyclosporine A in mice. , 1988, Transplantation proceedings.

[3]  T. A. Bell,et al.  Cyclosporin A: tissue levels following topical and systemic administration to rabbits. , 1986, The British journal of ophthalmology.

[4]  R. Hällgren,et al.  Renal interstitial fibrosis and vascular changes. Occurrence in patients with autoimmune diseases treated with cyclosporine. , 1986, Archives of internal medicine.

[5]  D. Benezra,et al.  Treatment and visual prognosis in Behçet's disease. , 1986, The British journal of ophthalmology.

[6]  R. Nussenblatt,et al.  Renal histopathologic alterations in patients treated with cyclosporine for uveitis. , 1986, The New England journal of medicine.

[7]  M. Wiederholt,et al.  Pharmacokinetic of topical cyclosporin A in the rabbit eye. , 1986, Investigative ophthalmology & visual science.

[8]  R. Nussenblatt,et al.  Cyclosporine penetration into the anterior chamber and cerebrospinal fluid. , 1985, American journal of ophthalmology.

[9]  R. Nussenblatt,et al.  Cyclosporin A therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents. , 1983, American journal of ophthalmology.

[10]  D. White,et al.  The Use of Cyclosporin A in clinical Organ Grafting , 1982, Annals of surgery.

[11]  R. Nussenblatt,et al.  Modulation of experimental autoimmune uveitis with cyclosporin A. , 1982, Archives of ophthalmology.

[12]  C. P. Wang,et al.  Species-specific cyclosporine metabolism. , 1988, Transplantation proceedings.

[13]  T. Chajek,et al.  Evaluation of Conventional Therapy Versus Cyclosporin a in Behcet’s Disease , 1987 .

[14]  M. Sanders,et al.  Cyclosporin A in the treatment of posterior uveitis. , 1985, Transactions of the ophthalmological societies of the United Kingdom.